Tetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles
A theranostic agent combines diagnostic reporter with therapeutic activity in a single entity,
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
[HTML][HTML] Tetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles
G Yu, TR Cook, Y Li, X Yan, D Wu, L Shao… - Proceedings of the …, 2016 - ncbi.nlm.nih.gov
A theranostic agent combines diagnostic reporter with therapeutic activity in a single entity,
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
Tetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles
G Yu, TR Cook, Y Li, X Yan, D Wu… - Proceedings of the …, 2016 - ui.adsabs.harvard.edu
Because of severe side effects, poor specificity, and lack of any ability to track the process of
translocation, clinic applications of platinum anticancer drugs are limited. New motifs that …
translocation, clinic applications of platinum anticancer drugs are limited. New motifs that …
Tetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles
G Yu, TR Cook, Y Li, X Yan, D Wu… - Proceedings of the …, 2016 - pubmed.ncbi.nlm.nih.gov
A theranostic agent combines diagnostic reporter with therapeutic activity in a single entity,
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
Tetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles
G Yu, TR Cook, Y Li, X Yan, D Wu, L Shao… - Proceedings of the …, 2016 - JSTOR
A theranostic agent combines diagnostic reporter with therapeutic activity in a single entity,
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
Tetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles.
G Yu, TR Cook, Y Li, X Yan, D Wu, L Shao… - Proceedings of the …, 2016 - europepmc.org
A theranostic agent combines diagnostic reporter with therapeutic activity in a single entity,
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
[引用][C] Tetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles
G Yu, TR Cook, Y Li, X Yan, D Wu, L Shao… - Proceedings of the …, 2016 - par.nsf.gov
[PDF][PDF] Tetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles
G Yua, TR Cookb, Y Lic, X Yand, D Wuc, L Shaoa… - supradrug.com
A theranostic agent combines diagnostic reporter with therapeutic activity in a single entity,
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …
Tetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles
G Yu, TR Cook, Y Li, X Yan, D Wu, L Shao… - Proceedings of the …, 2016 - cir.nii.ac.jp
抄録< jats: title> Significance</jats: title>< jats: p> Because of severe side effects, poor
specificity, and lack of any ability to track the process of translocation, clinic applications of …
specificity, and lack of any ability to track the process of translocation, clinic applications of …